Calquence 100 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F4C3L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,685
Award facts
- Contract value 100% obligated
- $17,684.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,684.91 delivery order to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-unit quantity) on November 25, 2025, with an ultimate completion date of December 17, 2025. This competitively awarded, firm fixed price contract carries no set-aside designation and will be performed at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Calquence is a targeted therapy used in the treatment of hematologic malignancies, reflecting the broad pharmaceutical procurement requirements of the Defense Logistics Agency's medical supply chain.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion vehicle running through December 2026 that serves as the primary pharmaceutical support mechanism for military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent competitive awards across the DLA medical supply chain demonstrate its capability to fulfill federal pharmaceutical procurement requirements across diverse product categories and order values.
Quick answers
Who was awarded contract SPE2DR26F4C3L?
SPE2DR26F4C3L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 25, 2025.
How much is contract SPE2DR26F4C3L worth?
The government has obligated $17,685 on SPE2DR26F4C3L.
Is contract SPE2DR26F4C3L an order under another contract?
Yes. SPE2DR26F4C3L is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4C3L competed?
The extent of competition for SPE2DR26F4C3L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award